Driving the evolution of therapies for chronic inflammatory disease.
Company Overview
Targeting the sources of chronic inflammatory diseases.
Our development programs are designed to offer underserved patient populations more than just symptomatic relief, with a favorable tolerability profile.
Evommune brings together the right team, with the right experience, at the right time.
Chronic inflammation is one of the most significant global health challenges, profoundly impacting patients’ quality of life and leading to life-threatening conditions. Left unchecked, chronic inflammation, ultimately leads to fatal diseases, including cardiovascular disease, diabetes and cancer, which contribute to three out of every five deaths worldwide and result in an estimated $90 billion of annual cost to the healthcare system in the United States.
The team at Evommune brings decades of collective experience to confront this challenge head-on, spanning all stages of discovery and development. With extensive R&D expertise in immunology and a proven track record of advancing novel therapies through regulatory pathways, our leadership has helped deliver medicines that have already benefitted millions of patients.